“showed a trend”

Glutamate levels also showed a trend toward elevation in the HFrD group relative to controls ( p = 0.074) (Fig. 2 A).

GDF-15 showed a trend toward moderate prediction of IS (AUC 0.69; p=0.074).

Also, patients with RBP4 sufficiency showed a trend of lower IgG1 concentrations compared to patients with insufficiency ( p = 0.074) ( Figure 2 D).

During training, the response to the ginger food odor combined with CS 2 showed a trend towards being greater than that evoked by presentation of the ginger food odor alone (paired t -test, t 84 = 1.81, p = 0.074, 10.4% ± 2.7—Figure 3C ).

Caffeine-treated bees showed a trend towards increased movement levels ( p = 0.074) and had significantly decreased grooming behaviour ( p = 0.045; Figure 7 ).

In a stage-adjusted Cox model, strong TLR4 expression showed a trend to association with a better prognosis; in the tumour front, the HR for overall survival was 1.8 ( P = 0.074, 95%CI: 0.9-3.3), and in the tumour bulk, it was 1.7 ( P = 0.059, 95%CI: 1.0-3.1).

The Pain scale showed a trend for higher rating in cervix group compared to the prostate group ( p = .074, r = 0.13).

The erm(T) gene showed a trend ( p = 0.074) of being more common in patients with GvHD.

Expression of NaPi-IIb fragment and TRPV6 in the duodenum of laying hens at two periods in response to dietary mineral P renunciation Among the main effects (period, strain, and diet) and their two- and three-way interactions, only the period × strain interaction was statistically significant for the expression of NaPi-IIb fragment ( P = 0.040) and showed a trend for TRPV6 ( P = 0.074), whereas all other effects were not significant ( P > 0.050; Fig. 1 ).

In patients treated with immunotherapy ( n = 217), the high 4‐1BB group ( n = 39) showed a trend towards longer progression‐free survival (PFS) (HR = 0.70, 95%CI: 0.47‐1.04, P = 0.074; Figure 1J ) and significantly longer OS (HR = 0.55, 95%CI: 0.33‐0.89, P = 0.016; Figure 1K ) compared to the low/moderate 4‐1BB group ( n = 178) (calculated from start of immunotherapy).

The ROC analysis showed a trend toward an improvement in diagnostic performance (AUC: 0.718, 95% CI: 0.50–0.93; p = 0.074). 3.2.

The mean AUC (during the 10 h test period) showed a trend for DNL to decrease from baseline to week 4 by 17.45%∗h in PXL770 subjects ( Figure 3 B, p = 0.074) in the mITT analysis.

15.4%, p =0.034) and showed a trend toward longer OS (2-year, 100% vs . 84.6%, p =0.074) than patients who had other metastatic diseases.

At lumbar spine M + 12, the Dmab → Dmab + Romo group showed a trend toward greater BMD increases compared to the Dmab → Dmab group (+ 3.2%, SE 4.4; p = 0.074), as did the Naïve → Romo group compared to Dmab → Dmab (+ 4.4%, SE 3.7; p = 0.064).

4A ); while it only showed a trend of decrease in cognitive impairment patients compared to non‐cognitive impairment patients, which was not statistically significant ( P = 0.074) (Fig. 4B ).

Higher amyloid PET SUVR showed a trend toward association with lower plasma Aβ42 levels (standardized β = −0.15, 95% CI [−0.31, 0.01], p = 0.074) (Figure 3A ) and was significantly associated with higher pTau181 (standardized β = 0.26, 95% CI [0.10, 0.42], p = 0.001) (Figure 3B ).

Urban residents showed a trend toward higher vaccination coverage than rural counterparts in the bivariate analysis ( p = 0.074), but this association did not reach statistical significance in the multivariate model.

Preoperative biomechanical characteristics FEA analysis run with patient-specific characteristics on preoperative CTAs presented in Table III by responder status showed a trend toward a lower mean ILT stress in the responder group compared with the nonresponders (7.2 kPa vs 7.6 kPa; P = .074).

Furthermore, the patients with anti-osteoporotic treatment showed a trend ( p = 0.074) towards having experienced a previous fracture more frequently.

Between-group comparison showed a trend toward better pain control in the HPTC group (p = 0.074) (Table 10 ).

pos 36.0%, P = 0.686), but patients with a positive microbiological colonization showed a trend towards receiving additional conservative treatment more frequently (pos 86.0% vs. neg 73.4%, P = 0.074).

Patients with a lower Total SUVmean (Total SUVmean≤16.04) only showed a trend of better DMFS (p = 0.074).

Immunohistochemical analyses of HER2 and Erk5 expression in the patient series showed a trend towards a positive correlation between high expression level of Erk5 and HER2 positivity ( p = 0.074).

Patients with an MVD above the median (23 MPF) showed a trend towards a longer OS compared to those with an MVD below the median (12.9 vs 10.1 months; P =0.074).

Only shortness of breath showed a trend toward being statistically significantly different when the two groups were compared using t-test (p=.074) or Wilcoxin test (p=.081).